美國國際貿易委員會確認蘋果(AAPL.US)Apple Watch心電圖功能侵權
美國國際貿易委員會(ITC)確認,蘋果(AAPL.US)具有心電圖(ECG)功能的Apple Watch侵犯醫療設備製造商AliveCor的專利。
ITC表示,侵權的Apple Watch應被禁止進口,但在美國專利商標局(USPTO)提出的另一宗糾紛上訴結束前,不會強制執行禁令,USPTO的一個小組本月裁定AliveCor的專利無效。
美國政府將有60日時間來考慮決定是否否決進口禁令,根據過去紀錄總統很少否決進口禁令。蘋果發聲明稱,絕不同意 ITC的決定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.